What are the differential diagnoses for hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hair Loss Differential Diagnosis

The differential diagnosis for hair loss should be systematically approached by first categorizing as scarring versus nonscarring, then by pattern (focal/patchy versus diffuse), as this framework guides both diagnosis and prognosis for patient outcomes 1, 2.

Primary Classification Framework

Hair loss divides into two fundamental categories with vastly different implications for reversibility and quality of life:

Nonscarring Alopecias (Hair follicles preserved - potential for regrowth)

Focal/Patchy Presentations:

  • Alopecia areata - Smooth patches with exclamation mark hairs at margins; may show yellow dots on dermoscopy. Distinguished by preserved, slightly reddened skin and characteristic broken hairs that pull out easily (unlike trichotillomania where hairs remain firmly anchored in anagen phase) 1, 2

  • Trichotillomania - Incomplete hair loss with irregular borders; broken hairs firmly anchored in scalp (still in anagen/growing phase). This is the most common diagnostic confusion with alopecia areata and may coexist 1, 2

  • Tinea capitis - Scalp inflammation present (though signs may be subtle); scaling often visible. Requires fungal culture when clinically suspected 1, 2

  • Traction alopecia - Pattern corresponds to hairstyling practices; hair-bearing margins affected by chronic tension 3

Diffuse Presentations:

  • Androgenetic alopecia (male/female pattern hair loss) - Most common cause overall. Males: temples, vertex, mid-frontal scalp. Females: central thinning with preserved frontal hairline. Genetic predisposition evident 4, 5, 3

  • Telogen effluvium - Acute or chronic diffuse shedding following precipitating event (stress, illness, medications, nutritional deficiency). Self-limited once trigger removed 1, 2, 5, 3

  • Anagen effluvium - Drug-induced (chemotherapy); can mimic diffuse alopecia areata 1, 2

  • Diffuse alopecia areata - More difficult to diagnose; may require scalp biopsy for confirmation 1, 5

Scarring Alopecias (Irreversible follicle destruction - urgent dermatology referral needed)

These carry worse prognosis for quality of life due to permanent hair loss:

  • Discoid lupus erythematosus 6
  • Lichen planus 6
  • Infectious causes (bacterial, fungal) 6
  • Trauma-related 6
  • Early scarring alopecia (may be difficult to distinguish initially) 1, 2

Critical Differential Considerations

When evaluating any hair loss patient, specifically exclude:

  1. Systemic lupus erythematosus - Check for systemic symptoms; serology indicated when suspected 1, 2

  2. Secondary syphilis - Can present with patchy hair loss; serology when clinically appropriate 1, 2

  3. Endocrine disorders - Thyroid dysfunction, hormonal imbalances affecting pattern and diffuse presentations 3

  4. Nutritional deficiencies - Though routine iron screening not recommended for alopecia areata specifically 1

  5. Medication-induced - Detailed medication history essential for anagen/telogen effluvium 3

Diagnostic Approach Algorithm

Step 1: Determine scarring versus nonscarring (examine scalp for follicular ostia preservation)

Step 2: If nonscarring, classify pattern:

  • Focal/patchy → Consider alopecia areata, trichotillomania, tinea capitis, traction alopecia
  • Diffuse → Consider androgenetic alopecia, telogen effluvium, diffuse alopecia areata, anagen effluvium

Step 3: Apply distinguishing clinical features:

  • Exclamation mark hairs = alopecia areata
  • Firmly anchored broken hairs = trichotillomania
  • Scalp inflammation/scaling = tinea capitis
  • Patterned distribution = androgenetic alopecia
  • Recent trigger event = telogen effluvium

Step 4: Confirm with targeted testing only when diagnosis uncertain:

  • Fungal culture (tinea capitis suspected)
  • Scalp biopsy (scarring vs nonscarring unclear, or diffuse alopecia areata)
  • Syphilis serology (appropriate clinical context)
  • Lupus serology (systemic symptoms present) 1, 2, 7

Common Diagnostic Pitfalls

Avoid routine screening for autoimmune disease, thyroid function, complete blood counts, or iron studies in straightforward alopecia areata cases - the increased frequency of autoimmune disease is insufficient to justify routine screening 1, 7. Only perform targeted testing when clinical suspicion exists.

Do not delay dermatology referral for suspected scarring alopecia - early intervention is critical as follicular destruction is irreversible and significantly impacts quality of life 6, 8.

Recognize that dermoscopy significantly improves diagnostic accuracy - yellow dots indicate active alopecia areata progression; cadaverized hairs (fractured before scalp emergence) distinguish alopecia areata from trichotillomania and scarring conditions 1.

The psychological impact on quality of life can be profound regardless of etiology, with patients experiencing anxiety, depression, reduced work productivity, and social withdrawal (SCARED behavior: shy, cautious, aggressive, retreating, evasive, defensive) 1, 3. This warrants serious attention even when the condition poses no direct threat to physical health.

References

Guideline

guidelines for the management of alopecia areata.

British Journal of Dermatology, 2003

Research

Hair Loss: Diagnosis and Treatment.

American family physician, 2024

Research

Approach to the adult female patient with diffuse nonscarring alopecia.

Journal of the American Academy of Dermatology, 2002

Research

Practical management of hair loss.

Canadian family physician Medecin de famille canadien, 2000

Research

A Clinical-Trichoscopic Two-Step Approach to Alopecia: A Systematic Review.

Clinical, cosmetic and investigational dermatology, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.